What will be the situation of China's pharmaceutical equipment industry in 2020? One text prediction

[market analysis of pharmaceutical network] in a flash, we have reached the end of 2019 In this critical period, some enterprises are busy summarizing and checking, some are busy planning and making new plans for the next year.. At the same time, next year's industry situation will also be concerned by the industry So, in 2020, what will happen to the pharmaceutical equipment industry in China? Pharmaceutical equipment (picture source: pharmaceutical network) let's first look at the situation of the pharmaceutical equipment industry in the first three quarters of 2019 From January to September 2019, among the enterprises that have disclosed their performance, the results are mixed The net profit of some leading enterprises has declined significantly, but the operating revenue of the main business has steadily increased, and the overall order is sufficient As for the reasons for the change of performance, major enterprises also mentioned in the announcement, including: increasing investment in research and development of new products and technologies during the reporting period, increasing research and development costs; increasing labor costs, increasing salary costs, etc It can be seen that, on the one hand, in the first three quarters of 2019, the intensity of R & D investment of pharmaceutical equipment enterprises is constantly increasing For example, truking mentioned in its performance forecast for the first three quarters of 2019 that its R & D expenses increased by 30% over the same period last year On the other hand, enterprises pay more attention to the introduction of talents Since the Spring Festival this year, the recruitment information of talents in the pharmaceutical equipment industry has attracted the attention of the industry Whether it is school recruitment or other recruitment channels, they are sending a signal: the competition for talents in the pharmaceutical equipment industry has begun! In the first three quarters of 2019, the concentration of pharmaceutical equipment industry has been increasing, and the market competition is more fierce For example, some enterprises continue to pay attention to the development of domestic and foreign pharmaceutical industry and market dynamics, optimize the operation mechanism and internal coordination of R & D management center, fully mobilize the innovation vitality of R & D system, break through technical difficulties, and meet market demand; some enterprises actively promote endogenous growth and external development, and gradually implement the "solid preparation intelligent factory as a whole" "Solution supplier" and the strategic layout of big health industry; there are also enterprises that continue to increase their efforts to explore new markets and invest in research and development of new products, strengthen brand effect and marketing network channel construction, and continue to promote collaborative management and quality improvement and efficiency enhancement In the second half of 2019, with the gradual implementation of the policy of expanding procurement with volume, the competition pattern of the domestic generic pharmaceutical market continues to be reshaped At the same time, pharmaceutical enterprises also face greater pressure, indirectly affecting the pharmaceutical equipment industry It is understood that as the principle of "price for quantity" is adopted in volume procurement, the bid winning pharmaceutical enterprises need to ensure the quality of drugs while reducing the price of drugs They are faced with the challenges of expanding production capacity and controlling costs The purchase requirements for pharmaceutical equipment are more stringent, and they tend to be pharmaceutical equipment with stable production capacity and high production efficiency Therefore, the pharmaceutical equipment with high degree of automation and intelligence is expected to usher in greater opportunities, which can help pharmaceutical enterprises to stabilize production and further reduce the cost of pharmaceutical enterprises In general, in 2019, China's pharmaceutical equipment manufacturing industry is working towards a medium and high level The traditional backward low-level equipment has been difficult to meet the needs of modern pharmaceutical industry Driven by the policies of consistency evaluation, medical insurance fee control, and volume purchase, the pace of structural transformation of China's pharmaceutical industry is accelerated In 2020, China's investment in high-level pharmaceutical equipment will further increase, driving the development of the overall level of the pharmaceutical equipment industry The industry expects that in the first half of 2020, the investment growth rate of China's pharmaceutical equipment manufacturing industry will increase In addition, it is worth noting that 2020 is the decisive year for China to build a moderately prosperous society in an all-round way, and stable growth will become the main keynote of this year's policy With the support of relevant policies, the production pace of pharmaceutical and other industries will be accelerated, or further promote the development of pharmaceutical equipment industry.